Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process

Anna Philip1, Valerie A Ferro1, Rothwelle J Tate1

  • 1Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK.

Abstract

Insights

Plant microRNAs (miRNAs) survive food processing and digestion, showing potential bioavailability in the human gut. This supports the dietary xenomiR hypothesis for exogenous gene regulation via food intake.

Area of Science:

  • Molecular Biology
  • Nutrition Science
  • Gastroenterology

Background:

  • The dietary xenomiR hypothesis suggests dietary microRNAs (miRNAs) can regulate gene expression in humans.
  • The bioavailability and stability of plant-derived miRNAs during digestion remain debated.
  • Understanding miRNA levels in food is crucial for assessing their potential as exogenous regulators.

Purpose of the Study:

  • To investigate the stability and bioavailability of plant miRNAs during food processing and simulated human digestion.
  • To provide an in vitro method for studying dietary miRNA uptake, avoiding in vivo complexities.

Main Methods:

  • Real-time PCR was used to quantify plant miRNA levels in soybean and rice.
  • Foodstuffs underwent simulated storage, processing, cooking, and digestion (75 min).
  • An in vitro simulated human digestion system was employed.

Main Results:

  • Plant miRNAs remained detectable in foodstuffs after storage, processing, and cooking.
  • Significant plant miRNA bioavailability was observed during early-stage simulated digestion.
  • Plant messenger RNA and synthetic miRNAs showed attenuation under simulated digestion conditions.

Conclusions:

  • Plant-derived miRNAs exhibit robustness, suggesting potential bioavailability after dietary ingestion.
  • The findings support the feasibility of dietary miRNAs acting as exogenous regulators.
  • Further exploration of plant miRNAs in pharma nutrition is warranted.

Related Concept Videos

Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
114
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
773